Fauci AS, et al. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321(9):844–5.

Article  PubMed  Google Scholar 

Prevention C.f.D.C.a. HIV Surveillance Report, 2020. 2022 [cited 2022 July 19th, 2022]; Available from: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.

Alpren C, et al. Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs—Massachusetts, 2015–2018. Am J Public Health. 2020;110(1):37–44.

Article  PubMed  PubMed Central  Google Scholar 

Golden MR, et al. Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs—Seattle, Washington, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(15):344–9.

Article  PubMed  PubMed Central  Google Scholar 

Hershow RB, et al. Notes from the field: HIV outbreak during the COVID-19 pandemic among persons who inject drugs—Kanawha County, West Virginia, 2019–2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):66–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyss SB, et al. Responding to outbreaks of human immunodeficiency virus among persons who inject drugs—United States, 2016–2019: perspectives on recent experience and lessons learned. J Infect Dis. 2020;222(Suppl 5):S239-s249.

Article  PubMed  Google Scholar 

Tookes H, et al. Rapid identification and investigation of an HIV risk network among people who inject drugs—Miami, FL, 2018. AIDS Behav. 2020;24(1):246–56.

Article  PubMed  Google Scholar 

Peters PJ, et al. HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015. N Engl J Med. 2016;375(3):229–39.

Article  CAS  PubMed  Google Scholar 

Rehm J, Probst C. Decreases of life expectancy despite decreases in non-communicable disease mortality: the role of substance use and socioeconomic status. Eur Addict Res. 2018;24(2):53–9.

Article  PubMed  Google Scholar 

Nambiar D, et al. Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982–2012. Drug Alcohol Depend. 2015;147:215–21.

Article  PubMed  Google Scholar 

Hser YI, et al. Mortality among substance-using mothers in California: a 10-year prospective study. Addiction. 2012;107(1):215–22.

Article  PubMed  Google Scholar 

Rehm J, et al. Trends in substance use and in the attributable burden of disease and mortality in the WHO European region, 2010–16. Eur J Pub Health. 2019;29(4):723–8.

Article  Google Scholar 

Chang C-K, et al. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry. 2010;10(1):1–7.

Article  CAS  Google Scholar 

Lindblad R, et al. Mortality rates among substance use disorder participants in clinical trials: pooled analysis of twenty-two clinical trials within the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2016;70:73–80.

Article  PubMed  PubMed Central  Google Scholar 

Iturralde E, et al. Premature mortality associated with severe mental illness or substance use disorder in an integrated health care system. Gen Hosp Psychiatry. 2021;68:1–6.

Article  PubMed  Google Scholar 

Gupta A, Arman Qamar MDa AF, Hainer J. Cocaine and marijuana use among young adults presenting with myocardial infarction: the partners YOUNG-MI Registry. 2018.

Degenhardt L, et al. Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend. 2011;113(2–3):88–95.

Article  PubMed  Google Scholar 

Huo D, Ouellet LJ. Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study. JAIDS J Acq Immune Defic Syndr. 2007;45(1):108–14.

Article  Google Scholar 

Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. The Lancet. 1997;349(9068):1797–800.

Article  CAS  Google Scholar 

Strathdee SA, et al. Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health. 1999;76(4):448–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strathdee SA, Vlahov D. The effectiveness of needle exchange programs: a review of the science and policy. AIDScience. 2001;1(16):1–33.

Google Scholar 

Vidourek RA, et al. Straight to the point: a systematic review of needle exchange programs in the United States. 2019.

Ruiz MS, et al. Using interrupted time series analysis to measure the impact of legalized syringe exchange on HIV diagnoses in Baltimore and Philadelphia. J Acq Immune Defic Syndr (1999). 2019;82(2):S148.

Article  Google Scholar 

Bartholomew TS, et al. Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: an interrupted time series analysis. Int J Drug Policy. 2020;84: 102875.

Article  PubMed  PubMed Central  Google Scholar 

Roth AM, et al. Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the Project SHE Demonstration Study. JAIDS J Acq Immune Defic Syndr. 2021;86(3):e61–70.

Article  Google Scholar 

Hood JE, et al. Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: lessons learned from Seattle, Washington. Subst Abuse. 2020;41(3):356–64.

Article  Google Scholar 

Lambdin BH, et al. Overdose education and naloxone distribution within syringe service programs—United States, 2019. Morb Mortal Wkly Rep. 2020;69(33):1117.

Article  CAS  Google Scholar 

Wakeman SE, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622–e1920622.

Article  PubMed  Google Scholar 

Roux P, et al. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clin Infect Dis. 2009;49(9):1433–40.

Article  PubMed  Google Scholar 

Felsher M, et al. An exploration of pre-exposure prophylaxis (PrEP) initiation among women who inject drugs. Arch Sex Behav. 2020;49(6):2205–12.

Article  PubMed  PubMed Central  Google Scholar 

Bachhuber MA, et al. Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program. Subst Abuse. 2018;39(2):167–72.

Article  Google Scholar 

Lambdin BH, et al. Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States. Drug Alcohol Depend. 2022;237:109504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castillo M, et al. Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic. Harm Reduct J. 2020;17(1):1–6.

Article  Google Scholar 

Mistler CB, Copenhaver MM, Shrestha R. The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review. AIDS Behav. 2021;25(5):1490–506.

Article  PubMed  Google Scholar 

Streed CG, et al. Prevalence of HIV preexposure prophylaxis prescribing among persons with commercial insurance and likely injection drug use. JAMA Netw Open. 2022;5(7):e2221346–e2221346.

Article  PubMed  PubMed Central  Google Scholar 

Prevention, C.f.D.C.a. HIV infection risk, prevention, and testing behaviors among Persons Who Inject Drugs—National HIV Behavioral Surveillance: Injection Drug Use, 23 U.S. Cities, 2018. HIV Surveillance Special Report 24. 2020 [cited 2022 June 17th]; Available from: https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.

Williams AR, et al. Development of a cascade of care for responding to the opioid epidemic. Am J Drug Alcohol Abuse. 2019;45(1):1–10.

Article  PubMed  PubMed Central  Google Scholar 

Stangl AL, et al. The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17(1):1–13.

Article  Google Scholar 

Thapa S, et al. Building a conceptual framework to study the effect of HIV stigma-reduction intervention strategies on HIV test uptake: a scoping review. J Assoc Nurses AIDS Care. 2017;28(4):545–60.

Article  PubMed  Google Scholar 

Tookes HE, et al. Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs. Drug Alcohol Depend. 2021;229:109124.

Article  PubMed  PubMed Central  Google Scholar 

Karch DL, et al. HIV infection care and viral suppression among people who inject drugs, 28 US jurisdictions, 2012–2013. Open AIDS J. 2016;10:127.

Article  PubMed  PubMed Central  Google Scholar 

Kim N, et al. Undiagnosed and untreated HIV infection among persons who inject drugs: results of three national HIV behavioral surveillance surveys, San Francisco, 2009–2015. AIDS Behav. 2019;23(6):1586–9.

Article  PubMed  Google Scholar 

Myers JE, et al. Redefining prevention and care: a status-neutral approach to HIV. Open Forum Infect Dis. 2018;5(6):ofy097.

Article  PubMed  PubMed Central  Google Scholar 

Curran GM, et al. Reflections on 10 years of effectiveness-implementation hybrid studies. Front Health Serv. 2022;2:1053496.

Article  PubMed  PubMed Central